Promega is launching the TarSeer BRETSA Target Engagement System, a live-cell, target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins,…
Promega, alongside several research institutions, announced recently the publication of a new study in Nature Communications, highlighting technological advances that may accelerate breakthroughs in precision medicine. According to a release,…
The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate MSI Dx Analysis System as a companion diagnostic designed to identify patients with microsatellite stable endometrial carcinoma who…
Promega has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase, the company announced today. According to a release, the enzyme will enhance Promega’s capabilities…
Promega has committed to set near-term company-wide emission reductions with the Science Based Targets initiative (SBTi), the company announced recently. According to a release, this commitment begins a defined process…
Promega and Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, are partnering, the companies recently announced. According to…
Promega and Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed and reproducibility, have partnered, the companies recently announced. According to a release, the partnership will expand…
Promega has partnered with EditCo Bio, a leader in engineered cell solutions, offering high-quality, functionally validated CRISPR-edited cell lines, the company announced recently. “This agreement accelerates scientific innovation by providing…
Promega’s HiBiT-PsVLP Bioassay will be used in the development of vaccines for infectious viral diseases and help support a collaboration between Charles River and the Coalition for Epidemic Preparedness Innovations’…
Promega announced today that it is collaborating with GSK, a global biopharma company, to plan, develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx) IVD kit. According to a…
